Učitavanje...
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Current pharmacological treatments for bipolar disorder (BD) are limited and efficacy has historically been discovered through serendipity. There is now scope for new drug development, focused on the underlying biology of BD that is not targeted by current therapies. The need for novel treatments is...
Spremljeno u:
| Izdano u: | Curr Neuropharmacol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Science Publishers
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761635/ https://ncbi.nlm.nih.gov/pubmed/26467413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150630175841 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|